Filing Details

Accession Number:
0001144204-14-058131
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-26 17:32:25
Reporting Period:
2014-09-24
Filing Date:
2014-09-26
Accepted Time:
2014-09-26 17:32:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315082 Ra Capital Healthcare Fund Lp 20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
1346824 Ra Capital Management, Llc 20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
1384859 Peter Kolchinsky 20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2014-09-24 175,720 $11.24 10,229,209 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-24 319,100 $11.25 9,910,109 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-24 210,109 $11.29 9,700,000 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-24 500,000 $11.28 9,200,000 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-25 116,186 $11.01 9,083,814 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-25 131,800 $11.06 8,952,014 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-25 250,000 $11.06 8,702,014 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-26 300,000 $11.12 8,402,014 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-26 120,000 $10.96 8,282,014 No 4 S Indirect See Footnotes
Common Stock, $0.001 Par Value Disposition 2014-09-26 250,000 $11.10 8,032,014 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
Footnotes
  1. The securities sold include 144,090 shares for by RA Capital Healthcare Fund, L.P. (the "Fund") and 31,630 shares for an account owned by Blackwell Partners, LLC (the "Blackwell Account").
  2. The securities sold include 261,662 shares for the Fund and 57,438 shares for an account owned by the Blackwell Account.
  3. The securities sold include 172,289 shares for the Fund and 37,820 shares for an account owned by the Blackwell Account.
  4. The securities sold include 410,000 shares for the Fund and 90,000 shares for an account owned by the Blackwell Account.
  5. The securities sold include 95,272 shares for the Fund and 20,914 shares for an account owned by the Blackwell Account.
  6. The securities sold include 108,075 shares for the Fund and 23,725 shares for an account owned by the Blackwell Account.
  7. The securities sold include 205,000 shares for the Fund and 45,000 shares for an account owned by the Blackwell Account.
  8. The securities sold include 246,000 shares for the Fund and 54,000 shares for an account owned by the Blackwell Account.
  9. The securities sold include 98,400 shares for the Fund and 21,600 shares for an account owned by the Blackwell Account.
  10. The securities sold include 204,999 shares for the Fund and 45,001 shares for an account owned by the Blackwell Account.
  11. Following the transactions set forth on Table I above 5,908,814 shares are held by the Fund, and 2,123,200 shares are held in the Blackwell Account.
  12. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Blackwell Account. Peter Kolchinsky is the sole manager of the Adviser. In their respective capacities, each of Mr. Kolchinsky and the Adviser may be deemed to beneficially own the reported securities.
  13. Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interests therein. The filing of this Form 4 shall not be construed as an admission that Mr. Kolchinsky or the Adviser is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of securities reported herein.